Response to once-monthly and daily oral ibandronate in women with postmenopausal osteoporosis: 2-year findings from mobile

被引：0
|
作者：
Stepan, J. J.
Kendler, D.
Sedarati, F.
Burdeska, A.
Hughes, C.
Lorenc, R.
机构：
[1] Univ Prague, Prague, Czech Republic
[2] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada
[3] Hoffmann La Roche Inc, Nutley, NJ 07110 USA
[4] F Hoffmann La Roche & Co Ltd, CH-4002 Basel, Switzerland
[5] Childrens Mem Inst, Warsaw, Poland
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2006年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：429 / 429
页数：1
相关论文
共 50 条
  • [41] Once-monthly oral ibandronate compared with weekly oral alendronate in postmenopausal osteoporosis: results from the head-to-head MOTION study
    Miller, Paul D.
    Epstein, Sol
    Sedarati, Farhad
    Reginster, Jean-Yves
    CURRENT MEDICAL RESEARCH AND OPINION, 2008, 24 (01) : 207 - 213
  • [42] Daily and once-monthly oral ibandronate have similar safety profiles in elderly and younger women: 1-year results from the mobile study.
    Miller, P
    Lewiecki, M
    Sol, E
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2005, 53 (04) : S194 - S194
  • [43] Monthly oral ibandronate therapy in postmenopausal osteoporosis: 1-year results from the MOBILE study
    Miller, PD
    McClung, MR
    Macovei, LV
    Stakkestad, JA
    Luckey, M
    Bonvoisin, B
    Reginster, JY
    Recker, RR
    Hughes, C
    Lewiecki, EM
    Felsenberg, D
    Delmas, PD
    Kendler, DL
    Bolognese, MA
    Mairon, N
    Cooper, C
    JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (08) : 1315 - 1322
  • [44] Tolerability of monthly oral ibandronate in postmenopausal osteoporosis: 1-year results from the MOBILE study
    Recker, RR
    Silverman, SL
    Kendler, DL
    Dumont, E
    Hughes, BBC
    Reginster, JY
    ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S293 - S294
  • [45] Regional distribution of spine and hip QCT BMD responses after one year of once-monthly ibandronate in postmenopausal osteoporosis
    Engelke, Klaus
    Fuerst, Thomas
    Dasic, Gorana
    Davies, Richard Y.
    Genant, Harry K.
    BONE, 2010, 46 (06) : 1626 - 1632
  • [46] Patient Satisfaction in Postmenopausal Women Treated with a Weekly Bisphosphonate Transitioned to Once-Monthly Ibandronate
    Bonnick, Sydney Lou
    Silverman, Stuart
    Tanner, S. Bobo
    Martens, Mark
    Bachmann, Gloria
    Kohles, Joseph D.
    Civitelli, Roberto
    JOURNAL OF WOMENS HEALTH, 2009, 18 (07) : 935 - 943
  • [47] Oral monthly ibandronate in postmenopausal osteoporosis: Rationale and design of the mobile study
    Cooper, C
    Delmas, PD
    Coutant, K
    Bonvoisin, B
    Recker, RR
    OSTEOPOROSIS INTERNATIONAL, 2003, 14 : S55 - S55
  • [48] QCT and FEA Assessment of Proximal Femur Bone Quality and Strength in Women with Postmenopausal Osteoporosis Receiving Once-Monthly Oral Ibandronate for 12 Months
    Kivitz, A.
    Keaveny, T. M.
    Genant, H. K.
    Engelke, K.
    Fuerst, T.
    Kopperdahl, D.
    Fries, M.
    Dasic, G.
    Fitzpatrick, L. A.
    Lewiecki, E. M.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2008, 23 : S230 - S230
  • [49] Monthly oral ibandronate is effective and safe therapy for women with postmenopausal osteoporosis: Mobile 1-year results.
    Epstein, S
    Bolognese, MA
    Miller, P
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2005, 53 (04) : S196 - S196
  • [50] Improved patient satisfaction with once-monthly ibandronate in women previously receiving once-weekly alendronate or risedronate for postmenopausal osteoporosis or osteopenia.
    Bonnick, S. L.
    Tanner, S. B.
    Martens, M.
    Civitelli, R.
    Kornowski, A.
    Silverman, S.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2006, 21 : S285 - S285
12345